MyFinsight
Home
Blog
About
Contact
Download
Download image
Cash and cash
equivalents
$10,955,359
Short-term investments
$2,916,701
Tax and other
receivables
$1,906,923
Collaboration receivables
$1,544,253
Prepaid expenses and
other current assets
$1,206,339
Prepaid collaboration
expenses
$153,273
Total current assets
$18,682,848
Intangible assets and
in-process r&d, net
$2,063,100
Operating lease
right-of-use assets
$301,486
Other assets
$88,153
Property and equipment,
net
$86,815
Restricted cash
$4,687
Total assets
$21,227,089
Total liabilities and
stockholders equity
$21,227,089
Total stockholders
equity
$13,934,561
Total liabilities
$7,292,528
Accumulated deficit
-$156,635,260
Accumulated other
comprehensive loss
-$228,796
Additional paid-in capital
$170,521,007
Total non-current
liabilities
$4,494,264
Total current
liabilities
$2,798,264
Common stock, 0.01 par
value 150,000,000...
$277,606
Preferred stock, 0.01 par
value 10,000,000...
$4
Contingent consideration
$2,946,743
Deferred collaboration
revenue
$1,250,000
Non-current operating lease
liabilities
$195,369
Deferred tax liability
$102,152
Accrued expenses
$2,025,173
Accounts payable
$594,874
Operating lease
liabilities
$178,217
Back
Back
Balance Sheet
KIORA PHARMACEUTICALS INC (KPHMW)
KIORA PHARMACEUTICALS INC (KPHMW)
source: myfinsight.com